Vote Scores

Home / Companies / Duality Biotherapeutics, Inc. / 29 Apr 2026

Meeting · year to 30 June 202625 filers reporting

Duality Biotherapeutics, Inc.: meeting of 29 Apr 2026

Votes reported on Form N-PX, item by item

25 Form N-PX filers reported votes at the Duality Biotherapeutics, Inc. meeting of 29 Apr 2026. Their records fall into 2 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

255 vote records from 25 filers. 2 of the 25 filers that marked the item either way voted against management.

92.0% for8.0% against8.0% against management25 filers98.9% for1.1% against1.1% against management38,232,026 reported shares, counted once per item in this group
2

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

141 vote records from 25 filers. 0 of the 25 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management25 filers99.4% for0.6% against0.6% against management23,943,418 reported shares, counted once per item in this group

How the largest families voted

None of the families tracked on this site reported a position on these items.

Questions

How did large funds vote at the Duality Biotherapeutics, Inc. meeting?

25 Form N-PX filers reported votes at the meeting of 29 Apr 2026. The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Duality Biotherapeutics, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Duality Biotherapeutics, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Duality Biotherapeutics, Inc. with a meeting date within three days of 29 Apr 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.